血液および血液成分の世界市場 (2022年-2028年)：市場予測 (製品・用途・エンドユーザー別)・地域的展望・用途の潜在性・価格動向・市場シェア

血液および血液成分の市場は、世界の癌患者数の増加により、2028年にかけて成長すると予測されています。

また、出血性疾患の有病率の高さも予測期間中の産業の成長に拍車をかけると考えられています。

製品別で見ると、世界の手術件数の急増により、血液成分の部門が2021年に115億米ドル超の規模を示し、2028年にかけて大幅な成長を示すと予測されています。また、用途別では、出血性障害の部門が2021年に23％超のシェアを示し、予測期間中も安定した成長を示すと予測されています。血液疾患患者は赤血球などの血液成分を頻繁に必要とするため、今後数年の成長が見込まれています。

当レポートでは、世界の血液および血液成分の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 血液および血液成分産業の考察

• 産業の分類
• 産業情勢
• 産業への影響要因
  • 成長要因
  • 潜在的リスク＆課題
• 成長の可能性
• COVID-19：影響分析
• 規制状況
• 産業のエコシステム
• ポーターの分析
• 競合情勢
• PESTEL分析

第4章 血液および血液成分市場：製品別

• 主要動向
• 全血
• 血液成分
  • 赤血球
  • 血小板
  • 血漿
  • 白血球

第5章 血液および血液成分市場：用途別

• 主要動向
• 貧血
• 外傷・手術
• 癌治療
• 出血性疾患
• その他

第6章 血液および血液成分市場：エンドユーザー別

• 主要動向
• 病院
• 外来手術センター
• その他

第7章 血液および血液成分市場：地域別

• 主要動向
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 企業プロファイル

• 競合ダッシュボード
• American Red Cross
• American Association of Blood Banks
• Association for the Advancement of Blood & Biotherapies
• The Associazione Volontari Italiani del Sangue(AVIS)
• Australian Red Cross
• Indian Red Cross
• Carter BloodCare
• OneBlood
• National Blood Authority Australia
• Versiti
• South African National Blood Service
• Vitalant

Data Tables

• TABLE 1 Blood and blood components industry 360 degree synopsis, 2017-2028 (USD million)
• TABLE 2 Global blood and blood components market, 2017-2021 (USD Million)
• TABLE 3 Global blood and blood components market, 2022-2028 (USD Million)
• TABLE 4 Global blood and blood components market, by product, 2017-2021 (USD Million)
• TABLE 5 Global blood and blood components market, by product, 2022-2028 (USD Million)
• TABLE 6 Global blood and blood components market, by application, 2017-2021 (USD Million)
• TABLE 7 Global blood and blood components market, by application, 2022-2028 (USD Million)
• TABLE 8 Global blood and blood components market, by end-use, 2017-2021 (USD Million)
• TABLE 9 Global blood and blood components market, by end-use, 2022-2028 (USD Million)
• TABLE 10 Global blood and blood components market, by region, 2017-2021 (USD Million)
• TABLE 11 Global blood and blood components market, by region, 2022-2028 (USD Million)
• TABLE 12 Industry impact forces
• TABLE 13 Whole blood market size, by region, 2017-2021 (USD Million)
• TABLE 14 Whole blood market size, by region, 2022-2028 (USD Million)
• TABLE 15 Blood components market size, by region, 2017-2021 (USD Million)
• TABLE 16 Blood components market size, by region, 2022-2028 (USD Million)
• TABLE 17 Red blood cells market size, by region, 2017-2021 (USD Million)
• TABLE 18 Red blood cells market size, by region, 2022-2028 (USD Million)
• TABLE 19 Platelets market size, by region, 2017-2021 (USD Million)
• TABLE 20 Platelets market size, by region, 2022-2028 (USD Million)
• TABLE 21 Plasma market size, by region, 2017-2021 (USD Million)
• TABLE 22 Plasma market size, by region, 2022-2028 (USD Million)
• TABLE 23 White blood cells market size, by region, 2017-2021 (USD Million)
• TABLE 24 White blood cells market size, by region, 2022-2028 (USD Million)
• TABLE 25 Anemia market size, by region, 2017-2021 (USD Million)
• TABLE 26 Anemia market size, by region, 2022-2028 (USD Million)
• TABLE 27 Trauma & surgery market size, by region, 2017-2021 (USD Million)
• TABLE 28 Trauma & surgery market size, by region, 2022-2028 (USD Million)
• TABLE 29 Cancer treatment market size, by region, 2017-2021 (USD Million)
• TABLE 30 Cancer treatment market size, by region, 2022-2028 (USD Million)
• TABLE 31 Bleeding disorders market size, by region, 2017-2021 (USD Million)
• TABLE 32 Bleeding disorders market size, by region, 2022-2028 (USD Million)
• TABLE 33 Others market size, by region, 2017-2021 (USD Million)
• TABLE 34 Others market size, by region, 2022-2028 (USD Million)
• TABLE 35 Hospitals market size, by region, 2017-2021 (USD Million)
• TABLE 36 Hospitals market size, by region, 2022-2028 (USD Million)
• TABLE 37 Ambulatory surgical centers market size, by region, 2017-2021 (USD Million)
• TABLE 38 Ambulatory surgical centers market size, by region, 2022-2028 (USD Million)
• TABLE 39 Others market size, by region, 2017-2021 (USD Million)
• TABLE 40 Others market size, by region, 2022-2028 (USD Million)
• TABLE 41 North America blood and blood components market size, by country, 2017-2021 (USD Million)
• TABLE 42 North America blood and blood components market size, by country, 2022-2028 (USD Million)
• TABLE 43 North America blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 44 North America blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 45 North America blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 46 North America blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 47 North America blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 48 North America blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 49 North America blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 50 North America blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 51 U.S. blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 52 U.S. blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 53 U.S. blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 54 U.S. blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 55 U.S. blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 56 U.S. blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 57 U.S. blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 58 U.S. blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 59 Canada blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 60 Canada blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 61 Canada blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 62 Canada blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 63 Canada blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 64 Canada blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 65 Canada blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 66 Canada blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 67 Europe blood and blood components market size, by country, 2017-2021 (USD Million)
• TABLE 68 Europe blood and blood components market size, by country, 2022-2028 (USD Million)
• TABLE 69 Europe blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 70 Europe blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 71 Europe blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 72 Europe blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 73 Europe blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 74 Europe blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 75 Europe blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 76 Europe blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 77 Germany blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 78 Germany blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 79 Germany blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 80 Germany blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 81 Germany blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 82 Germany blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 83 Germany blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 84 Germany blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 85 UK blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 86 UK blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 87 UK blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 88 UK blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 89 UK blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 90 UK blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 91 UK blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 92 UK blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 93 France blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 94 France blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 95 France blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 96 France blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 97 France blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 98 France blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 99 France blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 100 France blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 101 Spain blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 102 Spain blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 103 Spain blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 104 Spain blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 105 Spain blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 106 Spain blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 107 Spain blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 108 Spain blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 109 Italy blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 110 Italy blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 111 Italy blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 112 Italy blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 113 Italy blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 114 Italy blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 115 Italy blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 116 Italy blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 117 Russia blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 118 Russia blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 119 Russia blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 120 Russia blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 121 Russia blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 122 Russia blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 123 Russia blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 124 Russia blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 125 Asia Pacific blood and blood components market size, by country, 2017-2021 (USD Million)
• TABLE 126 Asia Pacific blood and blood components market size, by country, 2022-2028 (USD Million)
• TABLE 127 Asia Pacific blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 128 Asia Pacific blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 129 Asia Pacific blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 130 Asia Pacific blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 131 Asia Pacific blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 132 Asia Pacific blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 133 Asia Pacific blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 134 Asia Pacific blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 135 Japan blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 136 Japan blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 137 Japan blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 138 Japan blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 139 Japan blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 140 Japan blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 141 Japan blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 142 Japan blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 143 China blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 144 China blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 145 China blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 146 China blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 147 China blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 148 China blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 149 China blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 150 China blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 151 India blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 152 India blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 153 India blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 154 India blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 155 India blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 156 India blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 157 India blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 158 India blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 159 Australia blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 160 Australia blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 161 Australia blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 162 Australia blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 163 Australia blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 164 Australia blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 165 Australia blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 166 Australia blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 167 Latin America blood and blood components market size, by country, 2017-2021 (USD Million)
• TABLE 168 Latin America blood and blood components market size, by country, 2022-2028 (USD Million)
• TABLE 169 Latin America blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 170 Latin America blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 171 Latin America blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 172 Latin America blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 173 Latin America blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 174 Latin America blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 175 Latin America blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 176 Latin America blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 177 Brazil blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 178 Brazil blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 179 Brazil blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 180 Brazil blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 181 Brazil blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 182 Brazil blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 183 Brazil blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 184 Brazil blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 185 Mexico blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 186 Mexico blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 187 Mexico blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 188 Mexico blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 189 Mexico blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 190 Mexico blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 191 Mexico blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 192 Mexico blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 193 Argentina blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 194 Argentina blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 195 Argentina blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 196 Argentina blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 197 Argentina blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 198 Argentina blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 199 Argentina blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 200 Argentina blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 201 Middle East & Africa blood and blood components market size, by country, 2017-2021 (USD Million)
• TABLE 202 Middle East & Africa blood and blood components market size, by country, 2022-2028 (USD Million)
• TABLE 203 Middle East & Africa blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 204 Middle East & Africa blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 205 Middle East & Africa blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 206 Middle East & Africa blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 207 Middle East & Africa blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 208 Middle East & Africa blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 209 Middle East & Africa blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 210 Middle East & Africa blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 211 South Africa blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 212 South Africa blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 213 South Africa blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 214 South Africa blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 215 South Africa blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 216 South Africa blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 217 South Africa blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 218 South Africa blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 219 Saudi Arabia blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 220 Saudi Arabia blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 221 Saudi blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 222 Saudi Arabia blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 223 Saudi Arabia blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 224 Saudi Arabia blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 225 Saudi Arabia blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 226 Saudi Arabia blood and blood components market size, by end-use, 2022-2028 (USD Million)
• TABLE 227 UAE blood and blood components market size, by product, 2017-2021 (USD Million)
• TABLE 228 UAE blood and blood components market size, by product, 2022-2028 (USD Million)
• TABLE 229 UAE blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 230 UAE blood and blood components market size, by blood components, 2022-2028 (USD Million)
• TABLE 231 UAE blood and blood components market size, by application, 2017-2021 (USD Million)
• TABLE 232 UAE blood and blood components market size, by application, 2022-2028 (USD Million)
• TABLE 233 UAE blood and blood components market size, by end-use, 2017-2021 (USD Million)
• TABLE 234 UAE blood and blood components market size, by end-use, 2022-2028 (USD Million)

Charts & Figures

• FIG. 1 Bottom-up approach
• FIG. 2 Breakdown of primary participants
• FIG. 3 Blood and blood components industry 360 degree synopsis, 2017 - 2028
• FIG. 4 Industry segmentation
• FIG. 5 Global blood and blood components market, 2017 - 2028 (USD million)
• FIG. 6 Growth potential analysis, by product
• FIG. 7 Growth potential analysis, by application
• FIG. 8 Growth potential analysis, by end-use
• FIG. 9 Porter's analysis
• FIG. 10 Company matrix analysis, 2021
• FIG. 11 PESTEL analysis
• FIG. 12 Key segment trends, by product
• FIG. 13 Key segment trends, by application
• FIG. 14 Key segment trends, by end-use
• FIG. 15 Key regional trends
• FIG. 16 Competitive dashboard, 2021

The blood and blood components market is expected to gain impetus through 2028 owing to rising number of cancer patients across the globe. Additionally, high prevalence of bleeding disorders is likely to further fuel industry expansion over the forecast period.

A blood product refers to a therapeutic substance that is derived from human blood. Blood donation is crucial to ensure continuous supply of blood and blood components. The emergence of COVID-19 caused a significant decline in blood donations since people feared the risk of exposure to the novel coronavirus.

The ongoing blood shortage across several economies has prompted various organizations to initiate blood campaigns. The American Red Cross, the U.S.-based non-profit organization that covers 40% of blood supply needs in the nation, reportedly announced a national blood crisis, urging people to make blood and platelet donations.

The blood and blood components market has been bifurcated based on application, end-use, product, and region. In terms of product, the market has been split into whole blood and blood components. Of the total market revenue, the blood components sub-segment accounted for more than USD 11.5 billion in 2021 and is slated to witness substantial growth by 2028 due to rapid rise in surgeries worldwide.

Blood components consist of plasma, white blood cells (leukocytes), platelets, and red blood cells (erythrocytes). Blood components support highly complex medical and surgical procedures like transplantation, facilitating high-efficiency healthcare. Safe and quality-assured blood products help address child mortality and maternal healthcare. They also considerably improve life expectancy and quality for patients suffering from fatal diseases, such as cancer, thalassemia, hemophilia, traumatic hemorrhage, and others.

With respect to application, the blood and blood components market has been fragmented into cancer treatment, anemia, bleeding disorders, trauma & surgery, and others. Among these, the bleeding disorders sub-segment garnered above 23% market share in 2021 and is projected to grow at a steady pace over the review timeline. Patients suffering from hematology disorders frequently need blood components like red blood cells and others, which is projected to drive segmental demand in the coming years.

The American Cancer Society recorded about 60,650 new cases of leukemia and 24,000 deaths from the blood cancer in the region in 2022. Von Willebrand Disease (VWD) is the most common bleeding disorder affecting up to 1% of the global population. It occurs when a protein called the von Willebrand Factor (VWF) that is vital for blood clotting and coagulation is either absent or present in insufficient quantities.

Based on end-user, the blood and blood components market has been categorized into ambulatory surgical centers, hospitals, and others. In 2021, the ambulatory surgical centers (ASCs) sub-segment was valued at more than USD 2.5 billion and is anticipated to showcase significant growth over 2022-2028 driven by high patient preference and cost-effectiveness of these facilities.

On the regional front, the Latin America blood and blood components market is slated to exhibit sustainable growth at about 3.6% between 2022 and 2028. Several blood organizations like the Brazilian Red Cross would boost blood donations in the region, which is primed to foster market outlook in LATAM in the future.

Table of Contents

Chapter 1 Methodology

• 1.1 Market definitions
• 1.2 Base estimates & working
  • 1.2.1 North America
  • 1.2.2 Europe
  • 1.2.3 Asia Pacific
  • 1.2.4 Latin America
  • 1.2.5 MEA
• 1.3 Forecast parameters
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Secondary
    • 1.5.1.1 Paid sources
    • 1.5.1.2 Unpaid sources
  • 1.5.2 Primary

Chapter 2 Executive Summary

• 2.1 Blood and blood components industry 360 degree synopsis, 2017-2028
  • 2.1.1 Business trends
  • 2.1.2 Product trends
  • 2.1.3 Application trends
  • 2.1.4 End-use trends
  • 2.1.5 Regional trends

Chapter 3 Blood and Blood Components Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2017 - 2028
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing volume of surgeries globally
    • 3.3.1.2 Rising number of people from chronic conditions including cancer
    • 3.3.1.3 Growing popularity of plasma therapy to treat various sport injuries, cosmetic as well as orthopaedic procedures
    • 3.3.1.4 Several blood donation campaigns undertaken by various blood organizations
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Declining number of blood donations
    • 3.3.2.2 Transfusion transmitted infection (TTI) related to donated blood
• 3.4 Growth potential analysis
  • 3.4.1 By product
  • 3.4.2 By application
  • 3.4.3 By end-use
• 3.5 COVID-19 impact analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Industry ecosystem
  • 3.7.1 Supply chain analysis
• 3.8 Porter's analysis
• 3.9 Competitive landscape, 2021
  • 3.9.1 Company matrix analysis, 2021
• 3.10 PESTEL analysis

Chapter 4 Blood and Blood Components Market, By Product

• 4.1 Key segment trends
• 4.2 Whole blood
  • 4.2.1 Market size, by region, 2017-2028 (USD Million)
• 4.3 Blood components
  • 4.3.1 Market size, by region, 2017-2028 (USD Million)
  • 4.3.2 Red blood cells
    • 4.3.2.1 Market size, by region, 2017-2028 (USD Million)
  • 4.3.3 Platelets
    • 4.3.3.1 Market size, by region, 2017-2028 (USD Million)
  • 4.3.4 Plasma
    • 4.3.4.1 Market size, by region, 2017-2028 (USD Million)
  • 4.3.5 White blood cells
    • 4.3.5.1 Market size, by region, 2017-2028 (USD Million)

Chapter 5 Blood and Blood Components Market, By Application

• 5.1 Key segment trend
• 5.2 Anaemia
  • 5.2.1 Market size, by region, 2017-2028 (USD Million)
• 5.3 Trauma & Surgery
  • 5.3.1 Market size, by region, 2017-2028 (USD Million)
• 5.4 Cancer treatment
  • 5.4.1 Market size, by region, 2017-2028 (USD Million)
• 5.5 Bleeding disorders
  • 5.5.1 Market size, by region, 2017-2028 (USD Million)
• 5.6 Others
  • 5.6.1 Market size, by region, 2017-2028 (USD Million)

Chapter 6 Blood and Blood Components Market, By End-use

• 6.1 Key segment trend
• 6.2 Hospitals
  • 6.2.1 Market size, by region, 2017-2028 (USD Million)
• 6.3 Ambulatory surgical centres
  • 6.3.1 Market size, by region, 2017-2028 (USD Million)
• 6.4 Others
  • 6.4.1 Market size, by region, 2017-2028 (USD Million)

Chapter 7 Blood and Blood Components Market, By Region

• 7.1 Key regional trends
• 7.2 North America
  • 7.2.1 Market size, by country, 2017-2028 (USD Million)
  • 7.2.2 Market size, by product, 2017-2028 (USD Million)
    • 7.2.2.1 Market size, by blood components, 2017-2028 (USD Million)
  • 7.2.3 Market size, by application, 2017-2028 (USD Million)
  • 7.2.4 Market size, by end-use, 2017-2028 (USD Million)
  • 7.2.5 U.S.
    • 7.2.5.1 Market size, by product, 2017-2028 (USD Million)
      • 7.2.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.2.5.2 Market size, by application, 2017-2028 (USD Million)
    • 7.2.5.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.2.6 Canada
    • 7.2.6.1 Market size, by product, 2017-2028 (USD Million)
      • 7.2.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.2.6.2 Market size, by application, 2017-2028 (USD Million)
    • 7.2.6.3 Market size, by end-use, 2017-2028 (USD Million)
• 7.3 Europe
  • 7.3.1 Market size, by country, 2017-2028 (USD Million)
  • 7.3.2 Market size, by product, 2017-2028 (USD Million)
    • 7.3.2.1 Market size, by blood components, 2017-2028 (USD Million)
  • 7.3.3 Market size, by application, 2017-2028 (USD Million)
  • 7.3.4 Market size, by end-use, 2017-2028 (USD Million)
  • 7.3.5 Germany
    • 7.3.5.1 Market size, by product, 2017-2028 (USD Million)
      • 7.3.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.3.5.2 Market size, by application, 2017-2028 (USD Million)
    • 7.3.5.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.3.6 UK
    • 7.3.6.1 Market size, by product, 2017-2028 (USD Million)
      • 7.3.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.3.6.2 Market size, by application, 2017-2028 (USD Million)
    • 7.3.6.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.3.7 France
    • 7.3.7.1 Market size, by product, 2017-2028 (USD Million)
      • 7.3.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.3.7.2 Market size, by application, 2017-2028 (USD Million)
    • 7.3.7.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.3.8 Spain
    • 7.3.8.1 Market size, by product, 2017-2028 (USD Million)
      • 7.3.8.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.3.8.2 Market size, by application, 2017-2028 (USD Million)
    • 7.3.8.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.3.9 Italy
    • 7.3.9.1 Market size, by product, 2017-2028 (USD Million)
      • 7.3.9.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.3.9.2 Market size, by application, 2017-2028 (USD Million)
    • 7.3.9.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.3.10 Russia
    • 7.3.10.1 Market size, by product, 2017-2028 (USD Million)
      • 7.3.10.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.3.10.2 Market size, by application, 2017-2028 (USD Million)
    • 7.3.10.3 Market size, by end-use, 2017-2028 (USD Million)
• 7.4 Asia Pacific
  • 7.4.1 Market size, by country, 2017-2028 (USD Million)
  • 7.4.2 Market size, by product, 2017-2028 (USD Million)
    • 7.4.2.1 Market size, by blood components, 2017-2028 (USD Million)
  • 7.4.3 Market size, by application, 2017-2028 (USD Million)
  • 7.4.4 Market size, by end-use, 2017-2028 (USD Million)
  • 7.4.5 Japan
    • 7.4.5.1 Market size, by product, 2017-2028 (USD Million)
      • 7.4.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.4.5.2 Market size, by application, 2017-2028 (USD Million)
    • 7.4.5.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.4.6 China
    • 7.4.6.1 Market size, by product, 2017-2028 (USD Million)
      • 7.4.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.4.6.2 Market size, by application, 2017-2028 (USD Million)
    • 7.4.6.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.4.7 India
    • 7.4.7.1 Market size, by product, 2017-2028 (USD Million)
      • 7.4.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.4.7.2 Market size, by application, 2017-2028 (USD Million)
    • 7.4.7.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.4.8 Australia
    • 7.4.8.1 Market size, by product, 2017-2028 (USD Million)
      • 7.4.8.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.4.8.2 Market size, by application, 2017-2028 (USD Million)
    • 7.4.8.3 Market size, by end-use, 2017-2028 (USD Million)
• 7.5 Latin America
  • 7.5.1 Market size, by country, 2017-2028 (USD Million)
  • 7.5.2 Market size, by product, 2017-2028 (USD Million)
    • 7.5.2.1 Market size, by blood components, 2017-2028 (USD Million)
  • 7.5.3 Market size, by application, 2017-2028 (USD Million)
  • 7.5.4 Market size, by end-use, 2017-2028 (USD Million)
  • 7.5.5 Brazil
    • 7.5.5.1 Market size, by product, 2017-2028 (USD Million)
      • 7.5.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.5.5.2 Market size, by application, 2017-2028 (USD Million)
    • 7.5.5.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.5.6 Mexico
    • 7.5.6.1 Market size, by product, 2017-2028 (USD Million)
      • 7.5.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.5.6.2 Market size, by application, 2017-2028 (USD Million)
    • 7.5.6.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.5.7 Argentina
    • 7.5.7.1 Market size, by product, 2017-2028 (USD Million)
      • 7.5.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.5.7.2 Market size, by application, 2017-2028 (USD Million)
    • 7.5.7.3 Market size, by end-use, 2017-2028 (USD Million)
• 7.6 Middle East and Africa
  • 7.6.1 Market size, by country, 2017-2028 (USD Million)
  • 7.6.2 Market size, by product, 2017-2028 (USD Million)
    • 7.6.2.1 Market size, by blood components, 2017-2028 (USD Million)
  • 7.6.3 Market size, by application, 2017-2028 (USD Million)
  • 7.6.4 Market size, by end-use, 2017-2028 (USD Million)
  • 7.6.5 South Africa
    • 7.6.5.1 Market size, by product, 2017-2028 (USD Million)
      • 7.6.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.6.5.2 Market size, by application, 2017-2028 (USD Million)
    • 7.6.5.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.6.6 Saudi Arabia
    • 7.6.6.1 Market size, by product, 2017-2028 (USD Million)
      • 7.6.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.6.6.2 Market size, by application, 2017-2028 (USD Million)
    • 7.6.6.3 Market size, by end-use, 2017-2028 (USD Million)
  • 7.6.7 UAE
    • 7.6.7.1 Market size, by product, 2017-2028 (USD Million)
      • 7.6.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
    • 7.6.7.2 Market size, by application, 2017-2028 (USD Million)
    • 7.6.7.3 Market size, by end-use, 2017-2028 (USD Million)

Chapter 8 Company Profiles

• 8.1 Competitive dashboard, 2021
• 8.2 American Red Cross
  • 8.2.1 Business overview
  • 8.2.2 Financial data
  • 8.2.3 Product landscape
  • 8.2.4 Strategic outlook
  • 8.2.5 SWOT analysis
• 8.3 American Association of Blood Banks
  • 8.3.1 Business overview
  • 8.3.2 Financial data
  • 8.3.3 Product landscape
  • 8.3.4 Strategic outlook
  • 8.3.5 SWOT analysis
• 8.4 Association for the Advancement of Blood & Biotherapies
  • 8.4.1 Business overview
  • 8.4.2 Financial data
  • 8.4.3 Product landscape
  • 8.4.4 Strategic outlook
  • 8.4.5 SWOT analysis
• 8.5 The Associazione Volontari Italiani del Sangue (AVIS)
  • 8.5.1 Business overview
  • 8.5.2 Financial data
  • 8.5.3 Product landscape
  • 8.5.4 Strategic outlook
  • 8.5.5 SWOT analysis
• 8.6 Australian Red Cross
  • 8.6.1 Business overview
  • 8.6.2 Financial data
  • 8.6.3 Product landscape
  • 8.6.4 Strategic outlook
  • 8.6.5 SWOT analysis
• 8.7 Indian Red Cross
  • 8.7.1 Business overview
  • 8.7.2 Financial data
  • 8.7.3 Product landscape
  • 8.7.4 Strategic outlook
  • 8.7.5 SWOT analysis
• 8.8 Carter BloodCare
  • 8.8.1 Business overview
  • 8.8.2 Financial data
  • 8.8.3 Product landscape
  • 8.8.4 Strategic outlook
  • 8.8.5 SWOT analysis
• 8.9 OneBlood
  • 8.9.1 Business overview
  • 8.9.2 Financial data
  • 8.9.3 Product landscape
  • 8.9.4 Strategic outlook
  • 8.9.5 SWOT analysis
• 8.10 National Blood Authority Australia
  • 8.10.1 Business overview
  • 8.10.2 Financial data
  • 8.10.3 Product landscape
  • 8.10.4 Strategic outlook
  • 8.10.5 SWOT analysis
• 8.11 Versiti
  • 8.11.1 Business overview
  • 8.11.2 Financial data
  • 8.11.3 Product landscape
  • 8.11.4 Strategic outlook
  • 8.11.5 SWOT analysis
• 8.12 South African National Blood Service
  • 8.12.1 Business overview
  • 8.12.2 Financial data
  • 8.12.3 Product landscape
  • 8.12.4 Strategic outlook
  • 8.12.5 SWOT analysis
• 8.13 Vitalant
  • 8.13.1 Business overview
  • 8.13.2 Financial data
  • 8.13.3 Product landscape
  • 8.13.4 Strategic outlook
  • 8.13.5 SWOT analysis